Brief: Morphosys Q3 Net Loss Down 3% To EUR 119.6 Mln

Morphosys AG

15/11/2023 21:01

Nov 16 (Reuters) - MorphoSys AG  MORG.DE :
    * Q3 REVENUE DOWN 33% TO EUR 63.8 MILLION VERSUS EUR 95.8
MILLION
LAST YEAR
    * Q3 OPERATING LOSS UP 74% TO EUR 51 MILLION VERSUS EUR 29.3
MILLION LAST YEAR
    * Q3 RESEARCH AND DEVELOPMENT EXPENSES DOWN 19% TO EUR 63.2
MILLION VERSUS EUR 77.8 MILLION LAST YEAR
    * Q3 SELLING EXPENSES DOWN 15% AT EUR 19.9 MILLION VERSUS
EUR 23.5
MILLION LAST YEAR
    * Q3 CONSOLIDATED NET LOSS DOWN 3% TO EUR 119.6 MILLION
VERSUS EUR
122.9 MILLION LAST YEAR
    * Q3 MONJUVI U.S. NET PRODUCT SALES OF $23.4 MILLION (EUR
21.5
MILLION) VERSUS $22.2 MILLION (EUR 21.9 MILLION) LAST YEAR
    * 9M REVENUE DOWN 9% TO EUR 179.3 MILLION VERSUS EUR 196.7
MILLION
LAST YEAR
    * 9M CONSOLIDATED NET LOSS DOWN 50% TO EUR 238 MILLION
VERSUS EUR
480.5 MILLION LAST YEAR

Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))